Filing Details

Accession Number:
0001127602-14-012478
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-21 16:17:51
Reporting Period:
2014-03-20
Filing Date:
2014-03-21
Accepted Time:
2014-03-21 16:17:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875045 Biogen Idec Inc. BIIB Biological Products, (No Disgnostic Substances) (2836) 330112644
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1181174 Caroline Dorsa Biogen Idec Inc.
225 Binney Street
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-03-20 10,000 $53.64 24,468 No 4 M Direct
Common Stock Disposition 2014-03-20 2,200 $347.28 22,268 No 4 S Direct
Common Stock Disposition 2014-03-20 2,701 $348.66 19,567 No 4 S Direct
Common Stock Disposition 2014-03-20 4,199 $349.54 15,368 No 4 S Direct
Common Stock Disposition 2014-03-20 900 $350.37 14,468 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2014-03-20 10,000 $0.00 10,000 $53.64
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,000 2020-01-03 No 4 M Direct
Footnotes
  1. Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934
  2. This represents the weighted average price for shares purchased at a range between $347.06 (low) and $347.95 (high).
  3. Full information regarding the number of shares purchased at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
  4. This represents the weighted average price for shares purchased at a range between $348.09 (low) and $349.06 (high).
  5. This represents the weighted average price for shares purchased at a range between $349.11 (low) and $350.08 (high).
  6. This represents the weighted average price for shares purchased at a range between $350.11 (low) and $350.85 (high).
  7. The stock options become exercisable in three (3) equal annual installments commencing one year after the grant date of 01/04/2010.